Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether he plans to provide additional support for people with (a) arthritis and (b) musculoskeletal conditions.

Services for those with musculoskeletal (MSK) conditions, including arthritis, are commissioned locally by integrated care boards (ICBs). The Department expects MSK services and fragility fracture to be fully incorporated into integrated care system planning and decision-making.

At a national level, NHS England is working to improve the diagnosis, treatment, and care of patients with MSK conditions, such as arthritis, and increase support for patients with arthritis through its Getting It Right First Time rheumatology programme. In January 2023, NHS England also published an improvement framework to reduce community MSK waits while delivering the best outcomes and experience. This supports integrated care systems to improve timely access to commissioned MSK triage and therapy services.

To support health and care professionals in the early diagnosis and management of rheumatoid arthritis and osteoarthritis, and in the provision of services for people living with arthritis, the National Institute for Health and Care Excellence has published expert guidance for rheumatoid arthritis and osteoarthritis, with further information on the two available, respectively, at the following two links:

https://www.nice.org.uk/guidance/ng100

https://www.nice.org.uk/guidance/ng226

The Department funds research into MSK conditions, including arthritis, through the National Institute for Health and Care Research (NIHR). Through the NIHR, the Department spent approximately £26.3 million on MSK research in 2023/24 and £79.2 million since 2019/20. Six NIHR Biomedical Research Centres have MSK conditions as a research theme. In particular, the Leeds Biomedical Research Centre aims to improve treatment for osteoarthritis. The NIHR, in collaboration with Versus Arthritis, also funds a dedicated UK Musculoskeletal Translational Research Collaboration, aligning investment in MSK translational research, and creating a United Kingdom-wide ambition and focus to drive cutting edge research and improve outcomes for patients.